Register here

Date

Wednesday, November 18th 2020 (09:00) - Thursday, November 19th 2020 (12:40)

Price

€120.00 for non-members

€90.00 for members

Language

English

Organised by

Helis Academy

Categories

Tags

Are you into clinical research? Do you believe in patient centricity as a key innovation within clinical development and the healthcare industry? Then this two half days course on patient centricity and engagement is something for you. You will gain knowledge and insights that will allow you to put patient centricity into practice.

The culture of clinical development is evolving from one directed by researchers to one driven by patient needs and perspectives. Patients are no longer seen as mere subjects who generate data but as informed collaborators whose participation is vital for the overall success of clinical trials. Patient-oriented clinical development is increasingly becoming the model that the industry follows. Patient centricity means designing a clinical trial around the patient. Clinical trials often struggle with both patient enrolment and retention. Creating a patient-centric solution involves getting feedback from patients themselves and making decisions based on their needs and perspectives. Identifying and addressing unmet patient needs has become a key goal in clinical research. Patient-centric approaches to clinical trials are harnessed to achieve this goal.

But what does it mean to be patient centric, practically speaking? What tactics are leading pharma companies employing to make patient centricity a reality in their trials? What does patient centricity mean for your role as CRA or Clinical Trial Manager? And what does it mean from a patient perspective? This course is intended to provide an answer to these questions through lectures, testimonies and a panel discussion. You will learn how the biopharmaceutical industry collaborates with patient organizations in the clinical development of new medicines, diagnostics and medical devices. From contributing to the design of a clinical trial and improving the readability of the informed consent to providing valuable advice in making patient recruitment and retention more efficient. You will also learn how patient organizations help to communicate the existence of a clinical study within the group of interested patients.

Programme

Download the programme here.

Objectives

At the end of this short course you should have a clear understanding of:

  • What patient centricity means.

  • The role of patients in clinical trials.

  • The importance of strategy behind patient centric clinical trials.

  • Gaps and points of improvement concerning patient centricity in clinical trials.

  • The perspective on patient centricity from the point of view of a patient, a study coordinator, the FAMHP, a CRO and a biotech company.

Target group

This course is aimed at (Junior) CRA’s and Clinical Trial Managers who want to learn how to make patient centricity in clinical trials a reality.

Practical information

When? From 18-19 November 2020.

Where? This course will be organized as a digital event.

Registration fee? The registration fee for the two half days course is €120 (excl. VAT) for nonmembers and €90 (excl. VAT) for flanders.bio members, VIVES employees and students.

Registrations are open until the 16th of November 2020.

Organisers

This course is part of the Clinical Development theme of Helis Academy, a project funded by INTERREG and is organised by flanders.bio and Vives Hogeschool. More info about other courses can be found on the website of the Helis Academy.

Partners

The following companies and organisations are involved (as speakers) in the Helis Academy Patient centricity in clinical trials course for professionals: Patient Centrics – Esperity, EUPATI, Pivotal – Patient Journey, AZ Delta, FAMHP, IQVIA, Galapagos

Keep me informed

Leave your e-mail address and receive an e-mail if a new date is known for this course. Your email address will not be used for other purposes.

Terms and conditions

Performance of services

Flanders.bio and VIVES commit to perform the agreed training (Patient centricity in clinical trials course for professionals) to the best of their ability. In case of insufficient participation in or in case of force majeure prior to or during this training, flanders.bio has the right to cancel the course or to move it to a later time. When cancelled or postponed to a later date, any registration fees paid will be refunded.

Cancellation policy

Only written cancellations will be processed. If cancelled more than 1 week prior to the first day of training, an administration fee of €10 will be charged, except for unemployed job seekers. In case of cancellation on or after 1 week prior to the first day of training, half of the registration fee will be charged. Upon premature termination of participation to the two-day course, registration fees will not be refunded.

No show

If you are not present at the training (unless you are ill and in the possession of a doctor’s note) or do not cancel in time, the full registration fee will be charged.

Replacement

When unable to attend, a colleague can take your place. Report your hindrance and/or replacement of participation to flanders.bio as soon as possible. Replacement after the start of the training is not possible.

Registration fee

The registration fee for the two half days course is €120 (excl. VAT) for nonmembers and €90 (excl. VAT) for flanders.bio members, VIVES employees and students.

Certificate

At the end of the two half days training, participants which have followed the complete course will receive a certificate of participation.